Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 6, 2024; 12(13): 2243-2247
Published online May 6, 2024. doi: 10.12998/wjcc.v12.i13.2243
Rim 18F-fluorodeoxyglucose uptake of hepatic cavernous hemangioma on positron emission tomography/computed tomography: A case report
Yong-An Hu, Ya-Xin Guo, Qi-Feng Huang
Yong-An Hu, Ya-Xin Guo, Qi-Feng Huang, Department of Nuclear Medicine, Jinhua Hospital of Zhejiang University, Jinhua Municipal Central Hospital, Jinhua 321000, Zhejiang Province, China
Author contributions: All authors were involved in the preparation of this manuscript. Hu YA participated in data collection and wrote the manuscript; Guo YX participated in literature search and wrote the manuscript; Huang QF wrote and revised the manuscript; all authors have read and agreed to the published version of the manuscript.
Supported by Zhejiang Province Public Welfare Technology Application Research Project, No. LGF21H180007.
Informed consent statement: Written informed consent has been obtained from the patient to publish this paper.
Conflict-of-interest statement: All authors declare that they have no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Qi-Feng Huang, MD, Doctor, Department of Nuclear Medicine, Jinhua Hospital of Zhejiang University, Jinhua Municipal Central Hospital, No. 365 Renmin East Road, Jinhua 321000, Zhejiang Province, China. 1156225010@qq.com
Received: November 28, 2023
Revised: February 21, 2024
Accepted: April 3, 2024
Published online: May 6, 2024
Processing time: 149 Days and 5.3 Hours
Core Tip

Core Tip: Most of the hepatic cavernous hemangiomas (HCHs) are small, asymptomatic, and detected incidentally. The typical characteristics of HCHs on computed tomography or magnetic resonance imaging make their diagnosis straightforward. It has been suggested that low uptake of fluorodeoxyglucose could be useful to distinguish between benign hemangioma and malignant liver lesions. However, in the case presented here, a pathologically confirmed hepatic cavernous hemangioma showed a SUVmax (maximum standardized uptake value) in the margin of the lesion which was higher than that of the normal liver parenchyma. Therefore, clinicians should pay close attention to patients with hepatic mass.